In this video from AAO 2016, Dr. Michael Raizman discusses the latest treatments in seasonal and perennial allergic conjunctivitis. He recommends thorough patient education, advising against eye rubbing, and providing strategies for avoiding allergens. Current and conventional therapies include topical antihistamines, mast cell stabilizer drops, and corticosteroids. Potential future therapies under investigation include aldehyde traps, leukotriene receptor antagonists, and tumor necrosis factor alpha blockers. Newer drug delivery devices include drug-eluting contact lens and a slow-release punctal plug containing dexamethasone that might be close to approval.